Since this edition of NICE Bites was published, NICE has updated their guidance to replace the recommendation on using Sativex to treat spasticity in people with multiple sclerosis with a cross-reference to recommendations on THC:CBD spray in the NICE guideline on cannabis-based medicinal products (NICE NG144). A footnote was also amended to reflect a change in the law relating to gabapentin. Please go to NICE to check for any further updates to this guideline.
NICE Bites is a monthly bulletin from North West Medicines Information Centre which summarises key prescribing points from NICE guidance. NICE Bites No 72a, February 2015 includes one topic: Multiple sclerosis (NICE CG186). Sections covered include diagnosis, treatment and management of MS symptoms.
(This website entry checked November 2020)